Welcome to the prestigious conference; 4th World Congress on Sleep Disorders and Therapeutics scheduled on October 09-10, 2023 in Vancouver, Canada.
Sleep disorders are a group of conditions that affect the ability to sleep well on a regular basis. There are various types of sleep disorders, such as insomnia, sleep apnea, restless leg syndrome, narcolepsy, and parasomnias. These disorders can result in fatigue, daytime sleepiness, irritability, and difficulty concentrating, and can have negative impacts on overall health and quality of life.
Therapeutics for sleep disorders includes both non-pharmacological and pharmacological interventions. Non-pharmacological interventions can include sleep hygiene practices such as establishing a regular sleep schedule, avoiding stimulating activities before bedtime, and creating a comfortable sleep environment. Additionally, cognitive behavioral therapy (CBT) can be effective in treating insomnia and other sleep disorders by addressing underlying psychological factors.
Pharmacological interventions for sleep disorders can include prescription medications such as sedatives, hypnotics, and melatonin agonists. However, these medications can have side effects and can be habit-forming, making . In recent years, there has been growing interest limited, some studies suggest that these therapies may be effective for improving sleep quality and overall, the most effective approach to treating sleep disorders reducing symptoms of sleep disorders.
Target Audience:
Healthcare professionals
Researchers and academics
Corporations and employers
General public
Natural therapists
Medical Practitioners
Business/Practice Managers
Associations, Societies and Universities
Oriental Medicine Faculty
Treatment, Healing Centers and Rehabilitation Houses
CEO’s
Physicians
Deans
Professors
PhD Scholars
Session 1: Novel Insights to Sleep Disorders- Sleep disorders refer to a variety of conditions that affect the ability to fall asleep, stay asleep, or achieve restorative sleep. Recent research has revealed novel insights into these disorders, including the role of genetics and circadian rhythms in regulating sleep. Scientists have identified genetic variations that may contribute to sleep disorders, such as narcolepsy and insomnia.
Session 2: Business in Sleep Medicine- The field of sleep medicine has become increasingly important in recent years as sleep disorders have become more prevalent due to the demands of modern life. As a result, there are many opportunities for entrepreneurs and business owners to enter the sleep medicine industry and provide innovative solutions for those suffering from sleep disorders.
Session 3: Common Sleep Disorders: Causes and Treatment- There are several common sleep disorders that affect individuals. Some of the most prevalent ones include insomnia, sleep apnea, restless leg syndrome, and narcolepsy. Insomnia is a condition where individuals struggle to fall or stay asleep. Causes can include stress, anxiety, or medical conditions. Treatment can range from improving sleep hygiene habits to medication.
Session 4: Dental Sleep Medicine- Dental Sleep Medicine is a specialty field that focuses on the diagnosis and treatment of sleep-related breathing disorders, such as obstructive sleep apnea (OSA). Dentists trained in this field work alongside sleep physicians and other healthcare professionals to provide comprehensive care for patients with sleep-related breathing disorders. One of the main treatments for OSA is continuous positive airway pressure (CPAP) therapy, but many patients find it uncomfortable or are unable to tolerate it. Dental Sleep Medicine offers alternative treatments, such as oral appliance therapy, which involves wearing a custom-made mouth guard that helps to keep the airway open during sleep.
Session 5: Sleep Therapy Approaches- Sleep therapy approaches are designed to help individuals overcome sleep difficulties and improve the quality of their sleep. There are several different types of sleep therapy approaches that can be used depending on the specific needs of the individual. One common approach is cognitive-behavioral therapy for insomnia (CBT-I), which focuses on changing negative thoughts and behaviors that interfere with sleep.
Session 6: Hyper somnolence- Hyper somnolence is a medical condition characterized by excessive sleepiness during the day, even after a full night's sleep. It can be caused by various factors such as sleep apnea, narcolepsy, medication side effects, and certain neurological disorders. The symptoms of hyper somnolence include difficulty waking up in the morning, difficulty concentrating, memory problems, and mood changes.
Session 7: REM sleep Behavior Disorder- REM sleep behavior disorder is a parasomnia characterized by the absence of the normal paralysis during REM sleep, leading to acting out dreams. It can be dangerous, particularly if the individual becomes physically aggressive during a dream.
Session 8: Pediatric Sleep Disorders- Diagnosis and Treatment- Pediatric sleep disorders are common conditions that can negatively impact a child's health sleepwalking. Parents and caregivers can help promote healthy sleep habits for children by establishing a consistent sleep routine, limiting screen time before bed, and creating a comfortable sleep environment, development, and well-being. Diagnosis typically involves a thorough medical and sleep history, physical examination, and sleep studies if necessary.
Session 9: Mental and Physical Causes of Insomnia- Insomnia is a common sleep disorder that can have both mental and physical causes. Mental causes of insomnia may include stress, anxiety, depression, and other emotional factors. People who experience racing thoughts or worries may have difficulty falling asleep or staying asleep throughout the night. Physical causes of insomnia may include chronic pain, respiratory problems, heartburn, and restless leg syndrome. Certain medications or substances, such as caffeine or alcohol, can also contribute to insomnia.
Session 10: Obstructive Sleep Apnea during Pregnancy- Obstructive Sleep Apnea (OSA) is a sleep disorder that affects both men and women, including pregnant women. However, it is more common during pregnancy due to physiological changes that occur during this period. OSA is characterized by repeated episodes of complete or partial obstruction of the upper airway during sleep, leading to recurrent breathing pauses and disruptions in normal sleep patterns.
Session 11: Sleep, the Heart and the Brain- Sleep is essential for maintaining the health of both the heart and the brain. During sleep, the heart rate and blood pressure decrease, this helps to reduce the strain on the cardiovascular system. Lack of sleep has been associated with an increased risk of heart disease, stroke, and hypertension.
Session 12: Trends in Sleep medicine and therapy- Sleep medicine and therapy have seen several trends in recent years, including:
1. Digital Health: There has been a significant increase in the use of digital health tools, such as sleep tracking apps, to monitor and improve sleep quality.
2. Cognitive Behavioral Therapy for Insomnia (CBT-I): CBT-I is a non-pharmacological treatment that has gained popularity for its effectiveness in treating insomnia.
3. Sleep Apnea: With the rising incidence of obesity and aging populations, there has been an increase in sleep apnea cases, leading to the development of new treatments and therapies.
4. Telemedicine: The COVID-19 pandemic has accelerated the adoption of telemedicine in sleep medicine, allowing patients to receive care remotely.
5. Personalized Medicine: Advances in genetics and biomarker research have led to the development of personalized sleep medicine, tailoring treatments to an individual's unique needs.
Sleep disorders are a common problem, affecting millions of people worldwide. The most common sleep disorders are insomnia, sleep apnea, restless leg syndrome, and narcolepsy. These disorders can have a significant impact on quality of life, causing fatigue, irritability, and impaired cognitive function. As a result, there is a significant market for sleep disorder therapeutics.
Market Size and Growth: The global sleep disorder market was valued at $25.7 billion in 2020, and it is expected to grow at a compound annual growth rate (CAGR) of 7.9% from 2021 to 2028, reaching a value of $47.8 billion by 2028. This growth is driven by factors such as an increase in the prevalence of sleep disorders, rising awareness about the importance of sleep, and the introduction of new and innovative therapeutics.
Segmentation:The sleep disorder market can be segmented into four categories: diagnosis, treatment, sleep aids, and sleep labs.
Diagnosis: This segment includes diagnostic tools such as polysomnography, actigraphy, and home sleep testing. The diagnosis segment is expected to grow at a CAGR of 7.6% during the forecast period.
Treatment: The treatment segment includes medications, devices, and behavioral therapies. The treatment segment is expected to grow at a CAGR of 8.4% during the forecast period.
Sleep Aids: This segment includes over-the-counter and prescription sleep aids. The sleep aids segment is expected to grow at a CAGR of 6.9% during the forecast period.
Sleep Labs: This segment includes clinics and hospitals that offer sleep disorder testing and treatment services. The sleep labs segment is expected to grow at a CAGR of 8.3% during the forecast period.
Regional Analysis: North America dominates the global sleep disorder market, followed by Europe. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period, driven by factors such as an increase in the prevalence of sleep disorders, rising awareness about sleep health, and the adoption of new and innovative therapeutics.
Key Players: The global sleep disorder market is highly competitive, with several key players dominating the market. Some of the key players in the market include Eisai Co., Ltd., Takeda Pharmaceutical Company Limited, Merck & Co., Inc., Sanofi, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.
Conclusion: The global sleep disorder market is expected to grow significantly in the coming years, driven by factors such as an increase in the prevalence of sleep disorders, rising awareness about sleep health, and the adoption of new and innovative therapeutics. The market can be segmented into diagnosis, treatment, sleep aids, and sleep labs, and is dominated by key players such as Eisai, Takeda, and Merck.
